oligonucleotides – Discover Pharma

Welcome to Discover Pharma! Today is : July 11, 2026

oligonucleotides

Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
ten23 health secures Swissmedic ATMP manufacturing licences
ten23 health has obtained Good Manufacturing Practice (GMP) licences from [...]

June 30, 2026
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development
CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
AI therapeutics company, insitro, has agreed to acquire CombinAbleAI in [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
Symeres acquires DGr Pharma to enhance regulatory expertise and expand biopharma capabilities
Symeres, a global contract research, development and manufacturing organization, has [...]

May 5, 2026
Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden
Acquisition enhances innovation offering and expands biotech footprint across Nordic [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain
Solvias expands US cGMP testing capabilities with RTP center phase 2 build-out
Solvias has achieved Current Good Manufacturing Practice (cGMP) readiness at [...]

May 5, 2026
Manufacturing & Supply Chain
New GMP-certified QC services bolster Swiss-based CDMO’s end-to-end offering
May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK